AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Royalty Pharma Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for RPRX stock have an median target of 41, with a low estimate of 28 and a high estimate of 51. The median target predicts an increase of 58.67% from the current stock price of 25.84.
AI Analyst Report
According to 6 stock analyst, the rating for Royalty Pharma is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.